Genetic breakthrough could lead to cancer cure
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.American scientists said yesterday that a gene similar to one blamed for many types of cancer could open up a new way of attacking the killer disease.
William Kaelin Jr and researchers at the Dana Farber Cancer Institute and Harvard Medical School in Boston, Massachusetts examined the properties of "p73", a gene which is a close cousin to the tumour-suppressor gene p53, linked to more than 50 per cent of all cancer cases. When p53, the most important suppressor gene known, is mutated or not working, tumours can develop.
In a report in the scientific journal Nature, Mr Kaelin said that p73 can mimic the work of p53 - inducing cancer cells to die. "Our study shows that in principle there is actually another gene which is very similar to p53 and which could perform the functions normally performed by p53."
Mr Kaelin said that one of the reasons cancer cells don't die, and with a lot of genetic damage they should, is because they were smart enough to inactivate p53 which would ordinarily induce the damaged cells to commit suicide. "What our study shows is that when you activate this unknown53 homologue, p73, it will likewise induce cancer to undergo cell death."
The discovery of what p73 could lead to the development of new drugs that would activate the expression of the p73 gene, which so far does not appear to be frequently mutated in human cancer.
"You may have a copy of the p53-like gene that is in a somewhat dormant state that could then be activated by a drug." Mr Kaelin said. "Our study shows that if you did induce the expression of p73 in a cancer cell you could reasonably expect that the cell would undergo cell suicide."
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments